Articles
11 June 2009
Vol. 2 No. 15: Secondary Leukemias and leukemogenesis Rome, 3-4 November 2006
https://doi.org/10.4081/hmr.v2i15.512

Secondary leukemias and leukeogenesis

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
443
Views
184
Downloads

Authors

Giuseppe Leone
support@pagepress.org
Maria Teresa Voso
Livio Pagano
The last annual combined report from the American Cancer Society, NCI, CDC and NAACCR provided information on cancer rates and trends in United States from 1975 to 2002. This survey showed that among men the incidence rates for all cancer were stable, while among women they increased by 0.3% annually. On the other hand the overall cancer death rates decreased by 1.1% from 1993 through 2002.1 On this basis, there is a high number of patients surviving at long-term, at risk to develop a secondary acute myeloid leukemia or myelodysplastic syndromes (t-AML/ MDS).

Altmetrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



Secondary leukemias and leukeogenesis. (2009). Hematology Meeting Reports (formerly Haematologica Reports), 2(15). https://doi.org/10.4081/hmr.v2i15.512